Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Black Diamond Therapeutics, Inc. (BDTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K10-KS-1/A
Net income  -91.2-125.6-67.3-35.3-8.90.0
Depreciation and amortization   [+]0.50.20.10.00.00.0
Stock-based compensation  12.214.07.83.60.10.0
Change in working capital   [+]-7.18.75.70.50.4-0.2
Other operating activities  0.52.61.66.40.0-2.2
Cash from operations  -85.1-100.1-52.1-24.7-8.5-2.4
   
Capital expenditures   [+]-0.2-2.7-0.10.0-0.1-0.1
Sales of short-term investments  113.7182.890.9   
Other cash from investing  -60.1-49.5-372.5   
Cash from investing  53.4130.6-281.70.0-0.1-0.1
   
Issuance of common stock, net    213.8  0.1
Option exercises  0.20.71.1   
Financing costs     -1.7  
Other cash from financing  0.41.52.2126.052.39.9
Cash from financing  0.20.7214.9127.852.310.0
   
Free cash flow  -85.3-102.9-52.3-24.7-8.5-2.4
        Per share (diluted)  ($2.35)($2.84)($1.59)($11.90)($4.23)($1,261.89)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy